Subtle Medical

About

Subtle Medical is a healthcare technology company that offers AI-powered medical imaging.

Menlo Park,California,United States
11 - 50
https://subtlemedical.com/

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $25M
Industries: Artificial Intelligence,Health Care,Health Diagnostics,Machine Learning,Medical,Software
Founded date: Aug 1, 2017
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Subtle Medical Inc.
Also Known As: subtle

Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.

The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant to facilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.

Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$46.90M

Subtle Medical has raised a total of $46.90M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 17, 2022	Series B	$25M	8	—	—	Detail
Jan 26, 2022	Grant	—	1	National Institutes of Health (NIH)	—	Detail
Nov 20, 2020	Series A	$12.20M	7	3E Bioventures Fusion Fund	—	Detail
Aug 13, 2020	Grant	$1.60M	1	National Institutes of Health (NIH)	—	Detail
Jun 17, 2019	Seed	$3M	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

19

Subtle Medical is funded by 19 investors. National Institutes of Health (NIH) and 3E Bioventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institutes of Health (NIH)	Yes	Grant
3E Bioventures	—	Series B
Banyan Pacific	—	Series B
Crista Galli Ventures	—	Series B
Delta Capital	—	Series B
Eastern Bell Capital	—	Series B
Fusion Fund	—	Series B
Primavera Capital Group	—	Series B
SAV (Scale Asia Ventures)	—	Series B
DCVC	—	Series A